A study led by Jairo Kenupp Bastos from the Ribeirão Preto School of Pharmaceutical Sciences at the University of São Paulo has revealed that galloylquinic acids, extracted from the leaves of the Copaifera lucens tree native to Brazil's Atlantic Forest, may serve as effective antiviral agents against COVID-19. These compounds exhibit a unique ability to attack SARS-CoV-2 through various mechanisms: they block the virus from entering human cells, disrupt its replication, and dampen harmful inflammation. This multi-target approach is significant as it may reduce the potential for resistance to develop, a common issue with many existing antiviral treatments that target a single viral component. The research team conducted extensive laboratory tests, including cytotoxicity assessments and plaque reduction assays, confirming the compounds' efficacy against the virus. The findings, published in *Scientific Reports*, highlight the potential of these natural compounds and underscore the importance of biodiversity in medicine. Future research will focus on testing these compounds in living organisms and initiating clinical trials to evaluate their effectiveness in humans.